Literature DB >> 27583644

Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.

Jérome Chal1,2,3,4, Ziad Al Tanoury1, Marie Hestin2,3,4, Bénédicte Gobert1, Suvi Aivio2,3,4, Aurore Hick5, Thomas Cherrier1, Alexander P Nesmith6, Kevin K Parker6, Olivier Pourquié1,2,3,4.   

Abstract

Progress toward finding a cure for muscle diseases has been slow because of the absence of relevant cellular models and the lack of a reliable source of muscle progenitors for biomedical investigation. Here we report an optimized serum-free differentiation protocol to efficiently produce striated, millimeter-long muscle fibers together with satellite-like cells from human pluripotent stem cells (hPSCs) in vitro. By mimicking key signaling events leading to muscle formation in the embryo, in particular the dual modulation of Wnt and bone morphogenetic protein (BMP) pathway signaling, this directed differentiation protocol avoids the requirement for genetic modifications or cell sorting. Robust myogenesis can be achieved in vitro within 1 month by personnel experienced in hPSC culture. The differentiating culture can be subcultured to produce large amounts of myogenic progenitors amenable to numerous downstream applications. Beyond the study of myogenesis, this differentiation method offers an attractive platform for the development of relevant in vitro models of muscle dystrophies and drug screening strategies, as well as providing a source of cells for tissue engineering and cell therapy approaches.

Entities:  

Mesh:

Year:  2016        PMID: 27583644     DOI: 10.1038/nprot.2016.110

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  187 in total

Review 1.  Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects.

Authors:  J Rohwedel; K Guan; C Hegert; A M Wobus
Journal:  Toxicol In Vitro       Date:  2001-12       Impact factor: 3.500

2.  Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures.

Authors:  Jens Reimann; Karima Brimah; Rolf Schröder; Anton Wernig; Jonathan R Beauchamp; Terence A Partridge
Journal:  Cell Tissue Res       Date:  2003-11-26       Impact factor: 5.249

3.  Long-term microfluidic cultures of myotube microarrays for high-throughput focal stimulation.

Authors:  Anna Tourovskaia; Xavier Figueroa-Masot; Albert Folch
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Conditional conversion of ES cells to skeletal muscle by an exogenous MyoD1 gene.

Authors:  I Dekel; Y Magal; S Pearson-White; C P Emerson; M Shani
Journal:  New Biol       Date:  1992-03

5.  PAX-genes expression during human embryonic development, a preliminary report.

Authors:  M Gérard; M Abitbol; A L Delezoide; J L Dufier; J Mallet; M Vekemans
Journal:  C R Acad Sci III       Date:  1995-01

6.  Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.

Authors:  Jeanette Beers; Daniel R Gulbranson; Nicole George; Lauren I Siniscalchi; Jeffrey Jones; James A Thomson; Guokai Chen
Journal:  Nat Protoc       Date:  2012-10-25       Impact factor: 13.491

7.  Neural control of early myogenic differentiation in cultures of mouse somites.

Authors:  E Vivarelli; G Cossu
Journal:  Dev Biol       Date:  1986-09       Impact factor: 3.582

8.  Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.

Authors:  Francesco Saverio Tedesco; Mattia F M Gerli; Laura Perani; Sara Benedetti; Federica Ungaro; Marco Cassano; Stefania Antonini; Enrico Tagliafico; Valentina Artusi; Emanuela Longa; Rossana Tonlorenzi; Martina Ragazzi; Giorgia Calderazzi; Hidetoshi Hoshiya; Ornella Cappellari; Marina Mora; Benedikt Schoser; Peter Schneiderat; Mitsuo Oshimura; Roberto Bottinelli; Maurilio Sampaolesi; Yvan Torrente; Vania Broccoli; Giulio Cossu
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

9.  The consequences of a constitutive expression of MyoD1 in ES cells and mouse embryos.

Authors:  M Shani; A Faerman; C P Emerson; S Pearson-White; I Dekel; Y Magal
Journal:  Symp Soc Exp Biol       Date:  1992

Review 10.  Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges.

Authors:  Ramzey Abujarour; Bahram Valamehr
Journal:  Front Cell Dev Biol       Date:  2015-05-13
View more
  97 in total

1.  Micropatterned substrates with physiological stiffness promote cell maturation and Pompe disease phenotype in human induced pluripotent stem cell-derived skeletal myocytes.

Authors:  Nunnapas Jiwlawat; Eileen M Lynch; Brett N Napiwocki; Alana Stempien; Randolph S Ashton; Timothy J Kamp; Wendy C Crone; Masatoshi Suzuki
Journal:  Biotechnol Bioeng       Date:  2019-06-20       Impact factor: 4.530

Review 2.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

3.  Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA.

Authors:  Jaemin Kim; Vanessa K P Oliveira; Ami Yamamoto; Rita C R Perlingeiro
Journal:  Stem Cell Res       Date:  2017-07-12       Impact factor: 2.020

Review 4.  Towards stem cell therapies for skeletal muscle repair.

Authors:  Robert N Judson; Fabio M V Rossi
Journal:  NPJ Regen Med       Date:  2020-05-11

5.  Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture.

Authors:  Saowanee Jiwlawat; Eileen Lynch; Jennifer Glaser; Ivy Smit-Oistad; Jeremy Jeffrey; Jonathan M Van Dyke; Masatoshi Suzuki
Journal:  Differentiation       Date:  2017-08-01       Impact factor: 3.880

Review 6.  Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.

Authors:  Sridhar Selvaraj; Michael Kyba; Rita C R Perlingeiro
Journal:  Trends Mol Med       Date:  2019-09       Impact factor: 11.951

7.  ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.

Authors:  Michael R Hicks; Julia Hiserodt; Katrina Paras; Wakana Fujiwara; Ascia Eskin; Majib Jan; Haibin Xi; Courtney S Young; Denis Evseenko; Stanley F Nelson; Melissa J Spencer; Ben Van Handel; April D Pyle
Journal:  Nat Cell Biol       Date:  2017-12-18       Impact factor: 28.824

Review 8.  Stem cell-based therapies for Duchenne muscular dystrophy.

Authors:  Congshan Sun; Carlo Serra; Gabsang Lee; Kathryn R Wagner
Journal:  Exp Neurol       Date:  2019-10-19       Impact factor: 5.330

Review 9.  Stem cell therapy for muscular dystrophies.

Authors:  Stefano Biressi; Antonio Filareto; Thomas A Rando
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

10.  PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors.

Authors:  Alessandro Magli; Tania Incitti; James Kiley; Scott A Swanson; Radbod Darabi; Fabrizio Rinaldi; Sridhar Selvaraj; Ami Yamamoto; Jakub Tolar; Ce Yuan; Ron Stewart; James A Thomson; Rita C R Perlingeiro
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.